Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2019
A Look At The Financing, M&A And Alliance Activity In July–September 2019
Device financing increased substantially in Q3, thanks to debt raises led by Insulet. Acquisition dollar volume dropped, though, but Siemens' buy of Corindus for $1.1bn was a stand-out. Diagnostics/research tools financing dropped by 28% from Q2, while acquisition value greatly increased due to Exact Sciences' $2.8bn purchase of Genomic Health.
You may also be interested in...
CMR Surgical Bags $240M, Ready For Robotics Surgery Launch
UK robotics firm CMR Surgical has landed $240m from investors as it prepares to launch its robotic surgery system in Europe and India. The Series C raise is Europe’s largest private financing round in the medical technology sector to date.
Stryker Closes Gap With Competitors In Strategic Spinal Robotics Acquisition
Stryker is acquiring point-of-care imaging company Mobius Imaging and spine robotics company Cardan Robotics in a deal worth up to $500m.
Molecular Diagnostic Firms Curetis And OpGen Announce Merger
The combination of the molecular diagnostic companies is structured as an acquisition of Curetis by OpGen. The merged companies will be a based in the US.